Orchestra BioMed Holdings (OBIO) Current Assets (2020 - 2026)

Orchestra BioMed Holdings (OBIO) has 7 years of Current Assets data on file, last reported at $96.2 million in Q1 2026.

• On a quarterly basis, Current Assets rose 85.36% year-over-year to $96.2 million in Q1 2026; TTM through Mar 2026 was $96.2 million, a 85.36% increase from a year earlier, with the FY2025 full-year figure at $107.9 million, up 56.01% from the prior year.
• Current Assets for Q1 2026 stood at $96.2 million, down from $107.9 million in the prior quarter.
• Over the last five years, Current Assets for OBIO reached as high as $129.9 million in Q1 2023 and fell as low as $872555.0 in Q3 2022.
• Historically, Current Assets has averaged $71.0 million across 5 years, with a median of $76.4 million in 2024.
• Across the five-year window, Current Assets tumbled 53.2% in 2022 and surged 12528.32% in 2023, its largest moves.
• Year by year, Current Assets stood at $84.7 million in 2022, then increased by 5.22% to $89.1 million in 2023, then slipped by 22.38% to $69.2 million in 2024, then soared by 56.01% to $107.9 million in 2025, then slipped by 10.84% to $96.2 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $96.2 million in Q1 2026, $107.9 million in Q4 2025, and $97.8 million in Q3 2025.